Kantify

Avenue Louise 54
1050 Brussel (Elsene)
BE
Kantify
Foundation date
17/04/2015
Sector
#Biotechnology / R&D ServicesSubsector
- #R&D Services - Analytical services
- #R&D Services - Bioinformatics
- #R&D Services - CRO (Contract Research Organization)
- #R&D Services - Diagnostic services
- #R&D Services - Drug delivery
- #R&D Services - Proteomics
- #R&D Services - Screening
- #Other - AgBio
- #Pharma - Nucleic acid drugs
- #Pharma - Small molecule therapeutics
- #Medtech - Ophthalmic and optical devices
- #Professional Services - Business development
- #Professional Services - Communication & PR/IR
- #Professional Services - Deal arranger
- #Professional Services - Drug development consulting
- #Professional Services - Due diligence
- #Professional Services - Information provider
- #Professional Services - IT services
- #Professional Services - Legal services
- #Professional Services - Management consulting
- #Professional Services - Market access
- #Professional Services - Market research
- #Professional Services - Operations/Health & safety/Purchasing
- #Professional Services - Sales & Marketing
- #Professional Services - Technology transfer
- #Supplier - Software/eHealth
Therapeutic areas
Short description
Kantify is a startup based in Brussels with the mission to improve human health through Artificial Intelligence. Its core business is to build AI software solutions using state-of-the-art techniques accompanied by many in-house innovations, curated datasets, novel featurization techniques, and optimized infrastructure.
Expertise
AI-powered drug discovery:
Kantify has developed a unique end-to-end in silico drug discovery solution :
to help identify the macromolecule target that is causing the diseases
to find novel hits from diverse chemical scaffolds (in silico)
to predict promising lead compounds making sure they are both to be effective and not have adverse effects (ex: heart toxicity, liver toxicity, drug-drug interaction, etc.)
to reduce clinical trial failure rate by leveraging patient genomic data.
AI-powered clinical diagnostics and laboratory automation
to help diagnose endometrial diseases and uterus cancer from tissue images
to detect and predict heart failure and arrhythmia from signal data
to detect and segment beast cancer using whole-slide images, to perform complete blood-cell count and analysis from blood smear images (including Acute Leukemia detection)
to automate spermatozoa motility analysis.
Events by Kantify
All events-
1506 '22
Webinar on Targeted Protein Degraders and Artificial Intelligence
Event by: Kantify